Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStewart, S.en
dc.contributor.authorCarrington, M.en
dc.contributor.authorSwemmer, C.en
dc.contributor.authorKurstjens, N.en
dc.contributor.authorBrown, A.en
dc.contributor.authorBurrell, L.en
dc.contributor.authorNelson, M.en
dc.contributor.authorStocks, N.en
dc.contributor.authorJennings, G.en
dc.identifier.citationJournal of Clinical Hypertension, 2013; 15(9):674-680en
dc.description.abstractThis study sought to identify the determinants of early blood pressure (BP) control associated with monotherapy in hypertensive individuals being managed in the primary care setting. The Valsartan Intensified Primary Care Reduction of Blood Pressure (VIPER-BP) study, was a multicenter, randomized controlled trial of an intensive approach to BP management. During a standardized run-in, 2185 participants commenced monotherapy (valsartan 80 mg/d) for 14 to 28 days. A total of 1978 participants aged 59±12 years (60% men) completed the run-in phase. Of these, 15.1%, 43.5%, and 41.4% participants had an initial BP target of ≤125/75, 130/80, and 140/90 mm Hg, respectively. A total of 416 of 2185 participants (19.0%) subsequently achieved their individual BP target during run-in with a mean BP change of -22.6±12.1/-12.9±8.2 mm Hg vs -4.2±16.2/-3.0±9.6 mm Hg for the rest (P<.001). These early responders were more likely to be women (adjusted odds ratio, 1.41; 95% confidence interval, 1.10-1.80), had lower BP at baseline, were less likely to have been treated previously (or for less time), and had a less stringent BP target. An initial period of monotherapy achieved BP control in a high proportion of hypertensive individuals with key groups (including women and de novo cases) more likely to show an early BP response.en
dc.description.statementofresponsibilitySimon Stewart, Melinda J. Carrington, Carla H. Swemmer, Nicol P. Kurstjens, Alex Brown, Louise M. Burrell, Mark Nelson, Nigel P. Stocks, Garry L. Jenningsen
dc.publisherLe Jacq Communications, Incen
dc.rights©2013 Wiley Periodicals, Inc.en
dc.subjectVIPER-BP Study Investigators; Humans; Hypertension; Tetrazoles; Valine; Antihypertensive Agents; Treatment Outcome; Sex Factors; Blood Pressure; Aged; Middle Aged; Primary Health Care; Disease Management; Female; Male; Valsartanen
dc.titleDeterminants of achieving early blood pressure control with monotherapy in a primary care settingen
dc.typeJournal articleen
pubs.library.collectionGeneral Practice publicationsen
dc.identifier.orcidStewart, S. [0000-0001-9032-8998]en
dc.identifier.orcidBrown, A. [0000-0003-2112-3918]en
dc.identifier.orcidStocks, N. [0000-0002-9018-0361]en
Appears in Collections:General Practice publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.